Research
GLP-1 Drugs Linked to Improved Survival After Liver Transplant
The Brief
- A retrospective three-center cohort study of 2,402 liver transplant patients found that those taking a GLP-1 receptor agonist had a lower risk of death than those not on a GLP-1 drug.
- The findings were reported in MedPage Today's coverage of an AASLD meeting.
Why it matters
The study links GLP-1 receptor agonist use to better survival after liver transplant, a possible question for transplant clinicians. Because it is retrospective and observational, it can show an association but not prove that the drugs cause the difference.
Who’s affected
- hepatologists and liver transplant clinicians
- patients who have had a liver transplant and take or are considering GLP-1 drugs
- #liver transplant
- #glp-1 drugs
- #survival
- #cohort study
- #metabolic health
(MedPage Today) -- Liver transplant patients who took a GLP-1 receptor agonist had a lower risk of death than those who weren't on a GLP-1 drug, according to a retrospective three-center cohort study. Among 2,402 patients, those on GLP-1 receptor...